Stockscreener 앱 받기
71.43
4.44%
-3.32
시간 외 거래:
71.43
Dexcom Inc 주식(DXCM)의 최신 뉴스
Dexcom (DXCM) Chosen as First Participant in FDA's TEMPO Pilot - GuruFocus
At US$74.75, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List? - Moomoo
Dexcom Executive Chair Kevin R. Sayer Disposes of 26,756 Shares via Prearranged Rule 10b5-1 Plan - Kalkine Media
Dexcom Inc (DXCM) chair Kevin Sayer sells 26,756 shares under 10b5-1 plan - Stock Titan
DexCom Inc. stock outperforms competitors despite losses on the day - MarketWatch
Dexcom stock trades near 52-week high as G7 CGM growth supports earnings momentum - Ad-hoc-news.de
Are Medical Stocks Lagging DexCom (DXCM) This Year? - Yahoo Finance
DexCom Inc. stock underperforms Monday when compared to competitors - MarketWatch
Dexcom (NASDAQ: DXCM) executive plans 26,756-share stock sale - Stock Titan
Dexcom stock trades steady as diabetes CGM growth supports earnings outlook - Ad-hoc-news.de
Dexcom Inc. stock underperforms Thursday when compared to competitors despite daily gains - MSN
Dexcom stock holds steady as investors weigh Q1 2026 growth - ad-hoc-news.de
Enterprise value to EBIT forward of DexCom, Inc. – FWB:DC4 - TradingView
DexCom (DXCM) Back In Focus As Canada Approval Tests Its Valuation - Sahm
Dexcom stock trades steady as diabetes technology growth supports valuation - ad-hoc-news.de
DexCom Inc. stock underperforms Friday when compared to competitors - MarketWatch
DexCom Inc. Stock Climbs 7.2%, Outperforms Market - webull.com
DXCM5813816 Bond Profile — Key Metrics - TradingView
Form 4 DexCom Inc For: 16 July By Investing.com - Investing.com Nigeria
Dexcom stock trades steady as CGM demand supports revenue growth - ad-hoc-news.de
Truist raises DexCom stock price target to $87 on growth outlook By Investing.com - Investing.com South Africa
Dexcom EVP chief legal compliance off sells $126,514 in stock By Investing.com - Investing.com South Africa
DEXCOM INC : TRUIST SECURITIES RAISES TARGET PRICE TO $87 FROM $80 - Bitget
ETFs Investing in DexCom, Inc. Stocks - TradingView
DexCom Inc (DXCM) Stock Up 7.2% and Still Undervalued -- GF Scor - GuruFocus
DexCom, Inc.’s stock price soars to $77.98, marking a remarkable 7.22% increase - Smartkarma
Dexcom EVP chief legal compliance off sells $126,514 in stock - Investing.com
DEXCOM INC (DXCM) EVP reports 1,700-share planned stock sale in Form 4 - Stock Titan
DexCom Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Why DexCom (DXCM) Stock Is Up Today - Quiver Quantitative
Why DexCom Inc (DXCM) Is Set to Outperform the Market: Insights into Financial Growth and Competitive Advantage - GuruFocus
Truist raises DexCom stock price target to $87 on growth outlook - Investing.com
Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating - marketscreener.com
US252131AM9 Bond Profile — Key Metrics - TradingView
How Health Canada’s Longer-Wear CGM Approval At DexCom (DXCM) Has Changed Its Investment Story - simplywall.st
DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DXCM Company (NASDAQ: DXCM) shareholder to sell 1,700 shares - Stock Titan
DXCM Secures Health Canada Authorization for Dexcom G7 15 Day CGM - Zacks Investment Research
Dexcom G7 15 Day CGM System Receives Health Canada Approval - Medical Product Outsourcing
Dexcom receives Health Canada authorization for G7 15 Day CGM By Investing.com - Investing.com South Africa
Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights - GlobeNewswire Inc.
Dexcom (DXCM) Gains Health Canada Approval for New CGM System - GuruFocus
Dexcom G7 15 Day Receives Health Canada Authorization: Extending - GuruFocus
Dexcom receives Health Canada authorization for G7 15 Day CGM - Investing.com
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
DEXCOM,-INC. - The Facts
Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes - Dexcom Investor Relations
Here's why you should retain DexCom stock in your portfolio - MSN
Dexcom stock holds steady on its glucose monitor business - Ad Hoc News
JPMorgan (NYSE: JPM) sells $2.01M DexCom-linked auto callable contingent interest notes - Stock Titan
DEXCOM INC (NASDAQ:DXCM) Screens as a Strong Growth Stock with Favorable Technical Setup - ChartMill
Is DexCom (DXCM) Undervalued Following Its Investor Day Sentiment Shift? - Yahoo Finance
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - AOL.com
DexCom Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Dexcom to release Q2 2026 earnings on July 30, 2026 - scanx.trade
0.68%
1.19%
자본화:
|
볼륨(24시간):